Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial
Abdulrahman E. Koshak, Emad A. Koshak, Abdullah F. Mobeireek, et al.
Complementary Therapies in Medicine (2021) Vol. 61, pp. 102769-102769
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Nigella sativa L. Phytochemistry and Pharmacological Activities: A Review (2019–2021)
Mohammed Dalli, Oussama Bekkouch, Salah-eddine Azizi, et al.
Biomolecules (2021) Vol. 12, Iss. 1, pp. 20-20
Open Access | Times Cited: 68
Honey and Nigella sativa against COVID‐19 in Pakistan (HNS‐COVID‐PK): A multicenter placebo‐controlled randomized clinical trial
Sohaib Ashraf, Shoaib Ashraf, Moneeb Ashraf, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 2, pp. 627-644
Closed Access | Times Cited: 40
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
Mona A. Mohammed
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19
Vicente Amirpasha Tirado-Kulieva, Ernesto Hernández, Tania Jakeline Choque Rivera
Heliyon (2022) Vol. 8, Iss. 9, pp. e10702-e10702
Open Access | Times Cited: 26
Black Cumin Seed (Nigella sativa) in Inflammatory Disorders: Therapeutic Potential and Promising Molecular Mechanisms
Hager K. Rashwan, Shahenda Mahgoub, Nermeen Z. Abuelezz, et al.
Drugs and Drug Candidates (2023) Vol. 2, Iss. 2, pp. 516-537
Open Access | Times Cited: 15
Role of dietary supplements in the continuous battle against COVID‐19
Rahela Zaman, Vignesh Ravichandran, Chung Keat Tan
Phytotherapy Research (2024) Vol. 38, Iss. 2, pp. 1071-1088
Closed Access | Times Cited: 5
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
Harbans Singh, Sumit Srivastava, Babita Yadav, et al.
Complementary Therapies in Medicine (2022) Vol. 66, pp. 102814-102814
Open Access | Times Cited: 24
Can Essential Oils Provide an Alternative Adjuvant Therapy for COVID-19 Infections and Pain Management at the Same Time?
Roxana Damiescu, David Y.W. Lee, Thomas Efferth
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1387-1387
Open Access | Times Cited: 24
Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature
Mohd Imran, Shah Alam Khan, Abida Khan, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2750-2750
Open Access | Times Cited: 23
Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review
Munawar Abbas, Mayank Anand Gururani, Amjad Ali, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4914-4914
Open Access | Times Cited: 3
Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review
Yanxia Liu, Yanhe Zhou, Chang-Hong Jiang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5480-5508
Open Access | Times Cited: 20
Discover the Medication Potential of Algerian Medicinal Plants Against Sars-Cov-2 Main Protease (Mpro): Molecular Docking, Molecular Dynamic Simulation, and ADMET Analysis
Wafa Soudani, Hanane Zaki, Marwa Alaqarbeh, et al.
Chemistry Africa (2023) Vol. 6, Iss. 6, pp. 2879-2895
Open Access | Times Cited: 9
Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity
Sunil J. Wimalawansa
Heliyon (2024) Vol. 10, Iss. 15, pp. e34691-e34691
Open Access | Times Cited: 2
Pharmacologic effects approach of essential oils and their components on respiratory diseases
Jia Li, Wu Chen, Huimin Liu, et al.
Journal of Ethnopharmacology (2022) Vol. 304, pp. 115962-115962
Closed Access | Times Cited: 14
The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial
Shimaa A. Said, Alsayyed Abdulbaset, Amal A. El-Kholy, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial
Harbans Singh, Babita Yadav, K Amit, et al.
Complementary Therapies in Medicine (2023) Vol. 76, pp. 102966-102966
Open Access | Times Cited: 6
Pharmacological Profile of Nigella sativa Seeds in Combating COVID-19 through In-Vitro and Molecular Docking Studies
Subuhi Sherwani, R. Saravanan, Mohd Wajid Ali Khan, et al.
Processes (2022) Vol. 10, Iss. 7, pp. 1346-1346
Open Access | Times Cited: 10
Efficacy of Covexir® (Ferula foetida oleo‐gum) treatment in symptomatic improvement of patients with mild to moderate COVID‐19: A randomized, double‐blind, placebo‐controlled trial
Maede Hasanpour, Hossein Safari, Amir Hooshang Mohammadpour, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 12, pp. 4504-4515
Open Access | Times Cited: 10
The use of complementary and traditional medicine for the treatment of patients with COVID-19: A systematic review
Bárbara Badanta, Marta Alonso García, Ángela Estepa Jiménez, et al.
EXPLORE (2023) Vol. 19, Iss. 5, pp. 646-662
Open Access | Times Cited: 5
Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review
Hina Usmani, Saloni Malik, Anshu Arya, et al.
Recent Advances in Anti-Infective Drug Discovery (2023) Vol. 19, Iss. 1, pp. 3-11
Closed Access | Times Cited: 5
The Efficacy of Herbs as Complementary and Alternative Therapy in Recovery and Clinical Outcome Among People with COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression
Maria Komariah, Shakira Amirah, Sidik Maulana, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 611-627
Open Access | Times Cited: 5
Antibacterial and anti-corona virus (229E) activity of Nigella sativa oil combined with photodynamic therapy based on methylene blue in wound infection: in vitro and in vivo study
Sahar E. Abo‐Neima, Mostafa M. El‐Sheekh, Mayasar I. Al‐Zaban, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19
Matteo Micucci, Silvia Gioacchini, Melissa Baggieri, et al.
Future Foods (2024) Vol. 9, pp. 100303-100303
Open Access | Times Cited: 1
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection
Abdelrahim Maen, Betül Gök Yavuz, Yehia I. Mohamed, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The Potential of Natural Products in the Management of COVID-19
Mona M. Saber, Maha M. Salama, Osama A. Badary
Advances in experimental medicine and biology (2024), pp. 215-235
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top